Publications by authors named "Macarena Gonzalez Cruz"
Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.
Pediatr Blood Cancer
August 2024
Article Synopsis
- The EPICO-SEHOP platform in Spain collects COVID-19 data specifically from children, comparing those with cancer or recent stem cell transplants to those without underlying health issues.
- Findings show that children with cancer or who have undergone stem cell transplants generally experience milder COVID-19 symptoms (7.1%) compared to those without comorbidities (14.7%), unless they had a recent transplant (less than 300 days), where 35.7% faced severe illness.
- The shared data aims to inform treatment and isolation strategies, emphasizing the role of collaborative registries in addressing health crises during the pandemic.
Unlike adults, ovarian tumors are infrequent in the pediatric population, predominating the germ line at this age, with high survival rates. The objective is to present the epidemiological, clinical, diagnosis and therapeutic characteristics of 0 to 15-year-old patients diagnosed with ovarian tumor in our center between 2007 and 2017. Eight cases out of 171 diagnosed tumors (4.
View Article and Find Full Text PDFBackground/aim: L-Asparaginase (L-ASNase) is used as a tumor-inhibitory drug on paediatric acute lymphoblastic leukemia (ALL). ERW-ASNase is commercialised as a lyophilized powder stable only for 8 hours once reconstituted and, consequently, the leftover is usually discarded. The aim of this study will be to analyse the stability of the reconstituted lyophilised ERW-ASNase.
View Article and Find Full Text PDF